BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 18558863)

  • 21. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transmissible spongiform encephalopathies (prion diseases)--molecular principles and in vitro models].
    Kretzschmar H
    Wien Med Wochenschr; 1998; 148(4):67-73. PubMed ID: 9611345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prion protein: orchestrating neurotrophic activities.
    Martins VR; Beraldo FH; Hajj GN; Lopes MH; Lee KS; Prado MA; Linden R
    Curr Issues Mol Biol; 2010; 12(2):63-86. PubMed ID: 19767651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From cell protection to death: may Ca2+ signals explain the chameleonic attributes of the mammalian prion protein?
    Sorgato MC; Bertoli A
    Biochem Biophys Res Commun; 2009 Feb; 379(2):171-4. PubMed ID: 19101513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
    Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
    Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
    Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
    Prion; 2015; 9(5):394-403. PubMed ID: 26555211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into prion structure and toxicity.
    Harris DA; True HL
    Neuron; 2006 May; 50(3):353-7. PubMed ID: 16675391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
    Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
    Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prion protein glycosylation.
    Lawson VA; Collins SJ; Masters CL; Hill AF
    J Neurochem; 2005 May; 93(4):793-801. PubMed ID: 15857383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of PrP in health and disease.
    Flechsig E; Weissmann C
    Curr Mol Med; 2004 Jun; 4(4):337-53. PubMed ID: 15354865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolism of glycosaminoglycans is impaired in prion diseases.
    Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
    Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolving views in prion glycosylation: functional and pathological implications.
    Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
    Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scrg1 is induced in TSE and brain injuries, and associated with autophagy.
    Dron M; Bailly Y; Beringue V; Haeberlé AM; Griffond B; Risold PY; Tovey MG; Laude H; Dandoy-Dron F
    Eur J Neurosci; 2005 Jul; 22(1):133-46. PubMed ID: 16029203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenetic investigations of prion diseases of humans and animals.
    Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1993 Feb; 339(1288):239-54. PubMed ID: 8097053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the neurospecificity of Prion protein signaling.
    Schneider B; Pietri M; Pradines E; Loubet D; Launay JM; Kellermann O; Mouillet-Richard S
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):169-86. PubMed ID: 21196165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prion protein aggregation and fibrillogenesis in vitro.
    Stöhr J
    Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The state of the prion.
    Weissmann C
    Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.